Home › Trial NCT05850377
5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas
- Trial IDNCT05850377
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorSociedad de Lucha Contra el Cáncer del Ecuador
- Enrollment90
- Start date2023-06-01
- ConditionsHigh Grade Glioma · Glioma · Glioma, Malignant · Neoplasms, Neuroepithelial · Neuroectodermal Tumors · Photosensitizing Agents
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.